Labetalol S.A.L.F.

Labetalol, the active ingredient in Labetalol S.A.L.F., is a alpha/beta‑adrenergic blocker presented as an injectable solution for intravenous use. It treats hypertensive emergencies, severe hypertension, and hypertension in pregnancy such as pre‑eclampsia. Labetalol works by lowering heart rate, myocardial contractility and peripheral vascular resistance, providing rapid blood pressure control in critical settings.

GNH USA supplies Labetalol S.A.L.F. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Labetalol is used to manage conditions involving elevated blood pressure through combined alpha‑ and beta‑adrenergic blockade.

Hypertensive emergencies: rapid reduction of dangerously high blood pressure. Severe hypertension: sustained control of markedly elevated arterial pressure. Hypertension in pregnancy (e.g., pre‑eclampsia): safe intravenous management of pregnancy‑related high blood pressure.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dizziness or light‑headedness - Headache - Nausea or vomiting - Fatigue or weakness - Flushing or warmth sensation - Transient tachycardia

Serious or Rare Side Effects: - Severe hypotension leading to syncope - Bronchospasm, especially in patients with asthma - Hepatic dysfunction or elevated liver enzymes - Cardiac conduction abnormalities such as heart block - Allergic reactions including rash or anaphylaxis

Careful assessment and monitoring are required before and during therapy.

Monitor blood pressure closely: adjust infusion rate to avoid excessive hypotension. Assess for bronchospastic disease: use with caution in asthma or COPD. Evaluate hepatic function: dose may need adjustment in liver impairment. Avoid abrupt discontinuation: taper to prevent rebound hypertension. Check for cardiac conduction issues: avoid in patients with known heart block. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Labetalol may interact with other agents affecting cardiovascular tone or metabolism.

Major Interactions (Avoid): - Concomitant use with other potent antihypertensives (e.g., nitroprusside) may cause profound hypotension. - MAO inhibitors: risk of hypertensive crisis on abrupt withdrawal. - Calcium channel blockers (e.g., verapamil) can exacerbate bradycardia and AV block.

Moderate Interactions (Monitor Closely): - NSAIDs may attenuate antihypertensive effect. - Insulin or oral hypoglycemics: blood glucose may drop, requiring dose adjustment. - Anesthetic agents (e.g., halothane) may potentiate cardiovascular depression. - CYP2D6 inhibitors can increase plasma concentrations of labetalol.